$HR

Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call

NASHVILLE, Tenn., Oct. 14, 2025 ( GLOBE NEWSWIRE ) -- Healthcare Realty Trust Incorporated ( NYSE:HR ) today announced that on Thursday, October 30, 2025, after the market closes, it is scheduled to report results for the third quarter of 2025.

Original reporting
GlobeNewswire · Healthcare Realty Trust Incorporated
Published Oct 14, 2025, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Oct 14, 2025, 9:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Healthcare Realty Trust Announces Third Quarter Earnings Release Date and Conference Call — source image
Decision brief

The 30-second read

$HRBullishMed
01

Why it matters

Earnings results are likely to influence short-term stock performance; sector trends support a bullish bias.

02

Market read

High relevance due to upcoming earnings and sector-specific investor interest.

03

What to watch

Potential macroeconomic headwinds or sector-specific regulatory changes could negatively impact stock performance.

Timing: High, as earnings release is imminent.

Background

Healthcare Realty Trust is a prominent healthcare REIT with a focus on outpatient medical facilities.

Company-level read

Ticker impact

$HRBullishHigh confidence
Context

High relevance due to scheduled earnings report and positive sentiment.

Expected impact

Moderate upward movement expected prior to earnings release, with potential volatility post-announcement.

Evidence & confidence

The combination of scheduled earnings, positive sentiment, and sector relevance supports a bullish outlook in the near term.

Market effects

Positive outlook for healthcare real estate sector due to sector-specific earnings season.

Potential uplift in regional healthcare property markets, especially in the U.S.

Limited, as the focus is on U.S.-based healthcare REITs.

Counterpoint

Earnings may fall short of expectations, leading to a short-term decline despite positive sentiment.

Key entities

  • Healthcare Realty Trust

    A healthcare real estate investment trust (REIT) focused on outpatient facilities.

Related articles

$HRMedAI 8/10

Healthcare Realty Trust (HR) Q2 2026 Earnings Call Transcript

Healthcare Realty Trust (HR) reported Q2 2026 normalized FFO of $0.41/share and same-store cash NOI growth of 5.1% y/y. It raised normalized FFO guidance to $1.62 to $1.66/share and same-store cash NOI growth guidance to 4.3% to 5.0%. GAAP net loss was $0.13/share after $42.7m impairments. HR also discussed $200m JV acquisitions, $83m asset dispositions, and $75m Q2 repurchases.

$HRMed

Healthcare Realty Trust: Q2 Earnings Snapshot

Healthcare Realty Trust (HR) reported Q2 funds from operations of $143.7 million, or 41 cents per share, beating a Zacks-surveyed analyst average of 40 cents. The company posted a Q2 loss of $43.5 million, or 13 cents per share, and revenue of $281.8 million. Full-year FFO guidance is $1.62 to $1.66 per share.

$HRHigh

Healthcare Realty Trust Inc (HR): Results of Operations and Financial Condition

Healthcare Realty Trust Inc (HR) filed an SEC Form 8-K — Results of Operations and Financial Condition. News Release HEALTHCARE REALTY REPORTS SECOND QUARTER 2026 RESULTS AND FURTHER INCREASES FULL YEAR 2026 GUIDANCE NASHVILLE, Tennessee, July 30, 2026. Healthcare Realty Trust Incorporated (NYSE:HR) today announced results for the second quarter ended June 30, 2026. I n addition, t

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi